跳至主要内容
临床试验/DRKS00032173
DRKS00032173招募中不适用

IMITS longitudinal study: impact of malnutrition, sarcopenia, and a TIPS insertion on prognosis in liver cirrhosis - LIMITS

niversitätsmedizin Rostock, Abteilung für Gastroenterologie und Endokrinologie0 个研究点目标入组 140 人开始时间: 2023年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • confirmed liver cirrhosis
  • - consent ability

排除标准

  • - Unable or unwilling to attend follow-up appointments or unable to answer questionnaires (lack of mobility, lack of compliance, e.g., due to uncontrolled search disease)
  • - concomitant disease (COPD GOLD 3 or 4, heart failure NYHA 3 or 4, foreseeable need for major surgery)
  • - Active tumor disease including HCC (pre-existing malignant tumors or reasonable suspicion (e.g., hepatic lesions LIRADS 3 or 4); curatively treated tumors including HCC with no evidence of recurrence for >3 years and non-melanotic skin cancer are not exclusion criteria)
  • - Criteria of an ACLF fulfilled
  • - Diseases affecting musculoskeletal or joint function (e.g., apoplexy with paresis)
  • - Condition after major amputations
  • - History of eating disorders (e.g., anorexia nervosa, bulimia)
  • - Restricted food intake or absorption due to other conditions (e.g., achalasia, feeding via PEG, need for special diets (phenylketonuria), short bowel syndrome)
  • - Cardiac pacemaker/ defibrillator

研究者

发起方
niversitätsmedizin Rostock, Abteilung für Gastroenterologie und Endokrinologie

相似试验